Published ahead of print on July 12, 2007, doi:10.1164/rccm.200702-271OC
© 2007 American Thoracic Society doi: 10.1164/rccm.200702-271OC
Transfusion-related Acute Lung Injury in the Critically IllProspective Nested Case-Control Study1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, 2 Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, and 3 Division of Biostatistics, Department of Health Sciences Research, 4 Mayo Epidemiology and Translational Research in Intensive Care (METRIC), and 5 Department of Nursing, Mayo Clinic College of Medicine, Rochester, Minnesota Correspondence and requests for reprints should be addressed to Ognjen Gajic, M.D., Mayo Clinic, 200 First Street SW, Rochester, MN 55905. E-mail: gajic.ognjen{at}mayo.edu Rationale: Acute lung injury (ALI) that develops 6 hours after transfusion (TRALI) is the leading cause of transfusion-related mortality. Several transfusion characteristics have been postulated as risk factors for TRALI, but the evidence is limited to retrospective studies. Objectives: To compare patient and transfusion risk factors between patients who do and do not develop ALI. Methods: In this prospective cohort study, consecutive transfused critically ill patients were closely observed for development of ALI. Donor samples were collected from the transfusion bags. Risk factors were compared between patients who developed ALI after transfusion and transfused control patients, matched by age, sex, and admission diagnosis. Measurements and Main Results: Seventy-four of 901 transfused patients developed ALI within 6 hours of transfusion (8%). Compared with transfused control subjects, patients with ALI were more likely to have sepsis (37 vs. 22%, P = 0.016) and a history of chronic alcohol abuse (37 vs. 18%, P = 0.006). When adjusted for patient characteristics, transfusion of plasma from female donors (odds ratio [OR], 5.09; 95% confidence interval [95% CI], 1.37–18.85) rather than male donors (OR, 1.60; 95% CI, 0.76 to 3.37), number of pregnancies among the donors (OR, 1.19; 95% CI, 1.05 to 1.34), number of donor units positive for anti-granulocyte antibodies (OR, 4.85; 95% CI, 1.32–17.86) and anti–HLA class II antibodies (OR, 3.08; 95% CI, 1.15–8.25), and concentration of lysophosphatidylcholine in the donor product (OR, 1.69; 95% CI, 1.10 to 2.59) were associated with the development of ALI. Conclusions: Both patient and transfusion risk factors determine the probability of ALI after transfusion. Transfusion factors represent attractive targets for the prevention of ALI.
Key Words: fresh-frozen plasma platelet transfusion pulmonary edema female blood donors
Related articles in AJRCCM:
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||